↓ Skip to main content

Cytotoxic Effect of Thymoquinone-Loaded Nanostructured Lipid Carrier (TQ-NLC) on Liver Cancer Cell Integrated with Hepatitis B Genome, Hep3B

Overview of attention for article published in Evidence-based Complementary & Alternative Medicine (eCAM), August 2018
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
59 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cytotoxic Effect of Thymoquinone-Loaded Nanostructured Lipid Carrier (TQ-NLC) on Liver Cancer Cell Integrated with Hepatitis B Genome, Hep3B
Published in
Evidence-based Complementary & Alternative Medicine (eCAM), August 2018
DOI 10.1155/2018/1549805
Pubmed ID
Authors

Aminah Suhaila Haron, Sharifah Sakinah Syed Alwi, Latifah Saiful Yazan, Rohaina Abd Razak, Yong Sze Ong, Fatin Hannani Zakarial Ansar, Henna Roshini Alexander

Abstract

Thymoquinone (TQ), a bioactive compound found in Nigella sativa, cannot be orally consumed due to its lipophilicity. In order to overcome this low bioavailability, TQ is loaded into a colloidal drug carrier known as a nanostructured lipid carrier (NLC). This study aims to determine the antiproliferative effects of TQ and TQ-NLC on liver cancer cells integrated with the hepatitis B genome, Hep3B. The Hep3B was treated with TQ or TQ-NLC for 24, 48, and 72 hours via MTT assay. The results confirm that TQ or TQ-NLC inhibited the growth of Hep3B at IC50 <16.7 μM for 72 hours. TQ was also found to induce cell cycle arrest at the G1 checkpoint while TQ-NLC induced non-phase-specific cell cycle arrest. Further analysis using Annexin V staining confirmed the apoptotic induction of TQ or TQ-NLC via activation of caspases-3/7. In ROS management, TQ acted as a prooxidant (increased the level of ROS), while TQ-NLC acted as an antioxidant (reduced the level of ROS). Molecular analysis demonstrated that the GSH system and the Nrf2/Keap1 signaling pathway in Hep3B influenced the differential responses of the cells towards TQ or TQ-NLC. Hence, this study demonstrated that TQ and TQ-NLC have in vitro anticancer effects on the Hep3B.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 59 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 17%
Student > Master 9 15%
Student > Bachelor 6 10%
Researcher 2 3%
Student > Postgraduate 2 3%
Other 6 10%
Unknown 24 41%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 8 14%
Nursing and Health Professions 6 10%
Biochemistry, Genetics and Molecular Biology 5 8%
Medicine and Dentistry 5 8%
Agricultural and Biological Sciences 2 3%
Other 6 10%
Unknown 27 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 September 2018.
All research outputs
#21,544,627
of 26,447,081 outputs
Outputs from Evidence-based Complementary & Alternative Medicine (eCAM)
#5,502
of 9,360 outputs
Outputs of similar age
#257,136
of 328,623 outputs
Outputs of similar age from Evidence-based Complementary & Alternative Medicine (eCAM)
#133
of 197 outputs
Altmetric has tracked 26,447,081 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 9,360 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 328,623 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 197 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.